Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Sandesh Mahatme files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- RA CAPITAL MANAGEMENT, L.P. - $69.43M in VOR purchases and sales in the last 12 months
- Samarth Kulkarni - $10.47M in CRSP purchases and sales in the last 12 months
- Raju Prasad - $5.10M in CRSP purchases and sales in the last 12 months
- James R. Kasinger - $1.32M in CRSP purchases and sales in the last 12 months
- Reprogrammed Interchange LLC - $1.13M in VOR purchases and sales in the last 12 months
- Naimish Patel - $412K in CRSP purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Sandesh Mahatme?
Sandesh Mahatme is a corporate insider of CRISPR Therapeutics AG (CRSP). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Sandesh Mahatme last file a Form 4?
The most recent primary Form 4 on record is dated 9 June 2026, one of 2 filings going back to 2025.
